<DOC>
<DOCNO>
EP-0000322
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
C07C-209/00 C07C-211/00 C07C-209/28 A61K-31/405 A61K-31/4035 C07C-45/69 C07D-209/48 C07C-213/00 C07C-45/00 A61K-31/135 C07C-17/26 C07C-93/14 <main>C07C-87/28</main> C07C-49/223 C07C-17/00 C07C-217/00 A61K-31/44 C07C-211/29 C07D-213/38 C07C-67/00 C07C-87/29 C07C-217/80 C07C-17/14 C07C-209/08 C07C-209/40 C07C-49/00 A61K-31/403 A61P-25/00 C07C-211/28 C07C-49/235 C07C-211/27 C07C-209/16 C07C-217/62 C07C-45/74 C07D-209/00 
</IPC-CLASSIFICATIONS>
<TITLE>
compounds having an anti-depressive or tranquilizing activity, pharmaceutical compositions containing them, and processes and intermediates for their preparation.
</TITLE>
<APPLICANT>
astra laekemedel abse<sep>astra lakemedel aktiebolag<sep>astra läkemedel aktiebolagsträngnäsvägen 44151 85 södertäljese<sep>astra lakemedel aktiebolag<sep>
</APPLICANT>
<INVENTOR>
carnmalm bernt sigfrid emanuel<sep>de paulis tomas<sep>hogberg thomas<sep>ross svante bertil<sep>carnmalm, bernt sigfrid emanuel<sep>de paulis, tomas<sep>hogberg, thomas<sep>ross, svante bertil<sep>carnmalm, bernt sigfrid emanueltörnrosavägen 14s-151 52 södertäljese<sep>de paulis, tomasvillavägen 13s-150 11 björnlundase<sep>högberg, thomas vallmostigen 5s-150 20 järnase<sep>ross, svante bertilhedvägen 8s-151 52 södertäljese<sep>carnmalm, bernt sigfrid emanuel<sep>de paulis, tomas<sep>hogberg, thomas<sep>ross, svante bertil<sep>carnmalm, bernt sigfrid emanueltörnrosavägen 14s-151 52 södertäljese<sep>de paulis, tomasvillavägen 13s-150 11 björnlundase<sep>högberg, thomas vallmostigen 5s-150 20 järnase<sep>ross, svante bertilhedvägen 8s-151 52 södertäljese<sep>
</INVENTOR>
<ABSTRACT>
compounds of the formula    wherein the dotted line represents an optional double bond  and ar represents the group    wherein y is bound in the 2-, 3- or 4-position and represents a  lower alkyl or lower alkoxy group, a halogen, a trifluoromethyl  group or an amino, mono-or di-lower alkylamino group, or ar  represents a pyridyl group bound in the 2-, 3- or 4-position, x  represents hydrogen, a lower alkyl or lower alkoxy group, a  halogen, a trifluoromethyl group or an amino, mono- or di-lower  alkylamino group, r represents a lower alkyl group, and  r¹ represents hydrogen or a lower alkyl group, or a therapeutically  acceptable acid addition salt thereof, or a bioprecursor  thereof.  the compounds are prepared by various methods;  pharmaceutical compositions containing the compounds are  described.  
</ABSTRACT>
</TEXT>
</DOC>
